A Cy5.5-labeled anti-EGFR antibody, cetuximab, was used to image head and neck squamous cell carcinoma xenografts in vivo, and the results demonstrated the capability of a fluorescently labeled anti-EGFR antibody to be utilized for detecting human tumors in a surgical setting (18). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.